MedKoo Cat#: 413812 | Name: Diprafenone HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Diprafenone HCl is the salt form of Diprafenone Free Base, an antiarrhythmic beta adrenergic antagonist.

Chemical Structure

Diprafenone HCl
Diprafenone HCl
CAS#86342-43-0 (HCl)

Theoretical Analysis

MedKoo Cat#: 413812

Name: Diprafenone HCl

CAS#: 86342-43-0 (HCl)

Chemical Formula: C23H32ClNO3

Exact Mass: 405.2071

Molecular Weight: 405.96

Elemental Analysis: C, 68.05; H, 7.95; Cl, 8.73; N, 3.45; O, 11.82

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Diprafenone HCl; Diprafenone hydrochloride
IUPAC/Chemical Name
(+/-)-2'-(2-Hydroxy-3-(tert-pentylamino)propoxy)-3-phenylpropiophenone hydrochloride
InChi Key
UMNNDKJVNNYLDU-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H31NO3.ClH/c1-4-23(2,3)24-16-19(25)17-27-22-13-9-8-12-20(22)21(26)15-14-18-10-6-5-7-11-18;/h5-13,19,24-25H,4,14-17H2,1-3H3;1H
SMILES Code
O=C(C1=CC=CC=C1OCC(O)CNC(C)(C)CC)CCC2=CC=CC=C2.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 405.96 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Diprafenone. Drugs R D. 1999 Apr;1(4):301-3. doi: 10.2165/00126839-199901040-00004. PMID: 10566049. 2: Groschner K, Lindner W, Schnedl H, Kukovetz WR. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart. Br J Pharmacol. 1991 Mar;102(3):669-74. doi: 10.1111/j.1476-5381.1991.tb12231.x. PMID: 1364837; PMCID: PMC1917929. 3: Koytchev R, Alken RG, Mayer O. Effect of diprafenone on the pharmacokinetics of digoxin. Eur J Clin Pharmacol. 1996;50(1-2):97-100. doi: 10.1007/s002280050075. PMID: 8739818. 4: Hinderling PH, Tendolkar A, Dee CM, Barr WH, Seiberling M, Duerr H. Single- dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers. J Clin Pharmacol. 1995 Jul;35(7):721-9. doi: 10.1002/j.1552-4604.1995.tb04113.x. PMID: 7560253. 5: Greenberg S, Cantor E, Paul J. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol. J Cardiovasc Pharmacol. 1989 Sep;14(3):444-53. doi: 10.1097/00005344-198909000-00014. PMID: 2476625. 6: Nanoff C, Schütz W. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization. J Cardiovasc Pharmacol. 1991 Dec;18(6):837-42. doi: 10.1097/00005344-199112000-00008. PMID: 1725895. 7: Trenk D, Wagner F, Sachs W, Jähnchen E. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man. Eur J Clin Pharmacol. 1989;37(3):313-6. doi: 10.1007/BF00679792. PMID: 2612546. 8: Brunner F, Kolmayr U, Kukovetz WR. Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat. Arzneimittelforschung. 1989 Nov;39(11):1430-5. PMID: 2619776. 9: Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H. Diprafenon--Vergleichsstudie zur antiarrhythmischen Therapie mit Propafenon [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone]. Z Kardiol. 1988 Jul;77(7):464-9. German. PMID: 2463720. 10: Kodama I, Suzuki R, Honjo H, Toyama J. Electrophysiological effects of diprafenone, a dimethyl congener of propafenone on guinea-pig ventricular cells. Br J Pharmacol. 1992 Nov;107(3):813-20. doi: 10.1111/j.1476-5381.1992.tb14529.x. PMID: 1335340; PMCID: PMC1907742.